Bruker (BRKR) Cash & Current Investments (2010 - 2026)

Bruker (BRKR) has reported Cash & Current Investments for 17 consecutive years, with $217.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments rose 74.04% year-over-year to $217.2 million; the trailing twelve-month figure through Jun 2026 stood at $217.2 million (up 74.04% YoY), and the FY2025 full-year result was $322.6 million, up 53.99% from the prior year.
• Cash & Current Investments climbed to $217.2 million in Q2 2026 per BRKR's latest filing, from $161.6 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $916.1 million in Q1 2022 and bottomed at $124.8 million in Q2 2025.
• Historically, Cash & Current Investments has averaged $406.1 million across 5 years, with a median of $343.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 64.89% in 2024, then jumped 76.21% in 2025.
• Over 5 years, Cash & Current Investments stood at $664.5 million in 2022, then slipped by 22.18% to $517.1 million in 2023, then tumbled by 59.49% to $209.5 million in 2024, then surged by 53.99% to $322.6 million in 2025, then slumped by 32.67% to $217.2 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $217.2 million, $161.6 million, and $322.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.